Key Highlights

Risk & Performance

Pipeline Risk Assessment

Pipeline Risk Assessment

Based on historical performance

High Risk

Score: 65/100

Failure Rate

15.9%

97 terminated/withdrawn out of 609 trials

Success Rate

77.3%

-9.3% vs industry average

Late-Stage Pipeline

1%

9 trials in Phase 3/4

Results Transparency

57%

189 of 331 completed trials have results

Key Signals

84 recruiting189 with results71 terminated26 withdrawn

Enrollment Performance

Analytics

Phase 2
191(35.4%)
Phase 1
174(32.3%)
N/A
137(25.4%)
Early Phase 1
28(5.2%)
Phase 3
6(1.1%)
Phase 4
3(0.6%)
539Total
Phase 2(191)
Phase 1(174)
N/A(137)
Early Phase 1(28)
+2 more

Activity Timeline

Global Presence

Loading network data...

Clinical Trials (609)

Showing 20 of 609 trials
NCT05015426Phase 1Active Not Recruiting

Gamma Delta T-cell Infusion for AML at High Risk of Relapse After Allo HCT

Role: lead

NCT06350318Phase 2Recruiting

Rituximab and Zanubrutinib in Patients With Indolent B-cell Lymphomas

Role: lead

NCT04923542Phase 1Recruiting

SRS & Abemaciclib w/wo Imlunestrant in the Management of HR+/HER2- Breast CA Brain Metastases

Role: lead

NCT03451383Recruiting

Older Breast Cancer Patients: Risk for Cognitive Decline

Role: collaborator

NCT06144619Suspended

Non-Invasive Biomarkers in Prostate Cancer Disease Management

Role: lead

NCT05014282Not ApplicableActive Not Recruiting

Automated Video-Assisted Smoking Treatment for People Living With HIV

Role: lead

NCT07194044Phase 1Recruiting

Metastatic Ewing's Trial Testing Schedule Enhancement to Improve Outcomes

Role: lead

NCT06144606Phase 2Recruiting

Study of KTE-X19 in Minimal Residual Disease (MRD) Positive B-Cell Acute Lymphoblastic Leukemia (B-ALL)

Role: lead

NCT05528133Phase 2Recruiting

Genomically Guided Radiation Therapy in the Management of Triple Negative Breast Cancer

Role: lead

NCT05687188Active Not Recruiting

Evaluating Obesity-Mediated Mechanisms of Pancreatic Carcinogenesis in Minority Populations

Role: lead

NCT05004662Not ApplicableCompleted

Partnering With Food Bank to Provide Tobacco Treatment to Underserved Smokers

Role: lead

NCT04275557Active Not Recruiting

Using Radiogenomics to Predict Malignant Potential of Intraductal Papillary Mucinous Neoplasms of the Pancreas

Role: lead

NCT06305676Recruiting

Biomarker Approach to Screening for the Early Detection of HPV-related Oropharyngeal Cancer (BASH OPC)

Role: lead

NCT03387553Early Phase 1Completed

HER2 Directed Dendritic Cell Vaccine During Neoadjuvant Therapy of HER2+Breast Cancer

Role: lead

NCT06323291Early Phase 1Completed

Cancer Coaching and Remote Education for Self-Empowerment (CARES) Study

Role: lead

NCT06553872Phase 2Recruiting

Phase 2 Open Label Randomized Study of Pirtobrutinib and Brexucabtagene Autoleucel in R/R MCL

Role: lead

NCT06337552Not ApplicableActive Not Recruiting

High-Fermented Food Intervention Among Locally Advanced Rectal Cancer Patients (The FEED Trial)

Role: lead

NCT06423950Recruiting

Generating Novel Translational and Therapeutic Strategies Based on a Multicenter, Pediatric and AYA Evolutionary Tumor Board (pedsETB)

Role: lead

NCT06745882Phase 2Recruiting

Prospective Trial Assessing Real World Outcomes Response to Pembro in Black Patients w/ NSCLC

Role: lead

NCT05041335Not ApplicableWithdrawn

Wet Heparinized Suction for Abdominal Cancer

Role: lead